Allianz SE
ALIZF
OTC PK
$202.48
-$1.53-0.75%
Volume148
05/20/2022 3:08PM Eastern
Quotes delayed
| Weiss Ratings | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | -- | ||
| Risk Index | Weak | -- | ||
| Risk Grade | D | -- | ||
| Reward Grade | C+ | -- | ||
| Rating Factors | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Dividend Index | Excellent | -- | ||
| Growth Index | Weak | -- | ||
| Efficiency Index | Good | -- | ||
| Solvency Index | Excellent | -- | ||
| Total Return Index | Weak | -- | ||
| Volatility Index | Weak | -- | ||
| Beta / Standard Deviation | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Beta | 1.03 | -- | ||
| Price History | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.95% | -- | ||
| 30-Day Total Return | -13.38% | -- | ||
| 60-Day Total Return | -13.00% | -- | ||
| 90-Day Total Return | -21.98% | -- | ||
| Year to Date Total Return | -15.42% | -- | ||
| 1-Year Total Return | -23.35% | -- | ||
| 2-Year Total Return | 20.33% | -- | ||
| 3-Year Total Return | -11.24% | -- | ||
| 5-Year Total Return | 6.84% | -- | ||
| 52-Week High % Change | -25.56% | -- | ||
| 52-Week Low % Change | 3.67% | -- | ||
| Price | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| 52-Week High Price | $272.02 | -- | ||
| 52-Week Low Price | $195.31 | -- | ||
| 52-Week Low Price (Date) | Mar 07, 2022 | -- | ||
| 52-Week High Price (Date) | Jun 03, 2021 | -- | ||
| Valuation | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Market Cap | $84.04B | -- | ||
| Enterprise Value | 101.61B | -- | ||
| Price/Earnings (TTM) | 14.65 | -- | ||
| Earnings Per Share (TTM) | 13.82 | -- | ||
| Earnings Per Share Growth | -32.82% | -- | ||
| Price/Earnings To Growth | -- | -- | ||
| Price/Sales (TTM) | 0.79 | -- | ||
| Price/Book (Q) | 0.91 | -- | ||
| Enterprise Value/Revenue (TTM) | 1.00 | -- | ||
| Price | $202.48 | -- | ||
| Enterprise Value/EBITDA (TTM) | 18.00 | -- | ||
| Enterprise Value/EBIT | 23.99 | -- | ||
| Market Cap Category | Large Cap | -- | ||
| Dividends and Shares | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Shares Outstanding | 393.566M | -- | ||
| Dividend Yield | -- | -- | ||
| Div. Per Share (Most Recent) | $9.00 | -- | ||
| Dividend Per Share (TTM) | -- | -- | ||
| Payout Ratio (TTM) | -- | -- | ||
| Dividend Per Share (Most Recent) | $9.00 | -- | ||
| Company Info | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Phone Number | 49 89 3800 0 | -- | ||
| Address | -- | -- | ||
| Website | www.allianz.com | -- | ||
| Country | Germany | -- | ||
| Year Founded | 1890 | -- | ||
| Profitability | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | -- | ||
| Profit Margin | -- | -- | ||
| Management Effectiveness | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Return on Assets | -- | -- | ||
| Return on Equity | -- | -- | ||
| Income Statement | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | -- | ||
| Total Revenue (TTM) | -- | -- | ||
| Revenue Per Share | $257.28 | -- | ||
| Gross Profit (TTM) | -- | -- | ||
| EBITDA (TTM) | -- | -- | ||
| EBIT (TTM) | -- | -- | ||
| Net Income (TTM) | -- | -- | ||
| Net Income Avl. to Common (TTM) | -- | -- | ||
| Total Revenue Growth (Q YOY) | -18.53% | -- | ||
| Earnings Growth (Q YOY) | -108.33% | -- | ||
| EPS Diluted (TTM) | -- | -- | ||
| EPS Diluted Growth (Q YOY) | -121.76% | -- | ||
| Balance Sheet | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $39.15B | -- | ||
| Cash Per Share (Q) | $99.48 | -- | ||
| Total Current Assets (Q) | $154.65B | -- | ||
| Total Preferred Equity (Q) | -- | -- | ||
| Total Equity (Q) | $95.78B | -- | ||
| Current Ratio (Q) | 1.260 | -- | ||
| Book Value Per Share (Q) | $222.74 | -- | ||
| Total Assets (Q) | $1.30T | -- | ||
| Total Current Liabilities (Q) | $122.69B | -- | ||
| Total Debt (Q) | $45.49B | -- | ||
| Total Liabilities (Q) | $1.20T | -- | ||
| Total Common Equity (Q) | $90.93B | -- | ||
| Cash Flow | ALIZF - OTC PK | - | Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | -- | ||
| Cash from Financing (TTM) | -- | -- | ||
| Net Change in Cash (TTM) | -- | -- | ||
| Levered Free Cash Flow (TTM) | -- | -- | ||
| Cash from Operations (TTM) | -- | -- | ||
